R&D Structure Comprising the Central Development Function and Operating Companies
First written in FY2016. 27 of 30 entries say "Restated". Latest entry: FY2026.
Citizen Watch moved to the "Worse" side of this theme in 2026.
1 other company's latest entry also says "Reframed".
- FY2026ReframedAnnual report
「The company’s R&D Department serves as the central development function and conducts R&D across the group in line with management policies. Product development, production technology development and other activities related to each business are handled by the product development and technology development divisions of the Watch Business, as well as by each operating company.」
The central development function was described as being handled by the R&D Department rather than the R&D Center, with a division of responsibilities among the business-specific development divisions and each operating company. R&D expenses were ¥5,774 million. - FY2026-H1RestatedAnnual report
「The group’s total R&D expenses for the interim consolidated accounting period were ¥2,944 million. There were no material changes in the status of the group’s R&D activities during the interim consolidated accounting period.」
There were no material changes in the central development function or the R&D structure involving the operating companies, and R&D expenses were ¥2,944 million. - FY2025-H1RestatedAnnual report
「The group’s total R&D expenses for the interim consolidated accounting period were ¥2,842 million. There were no material changes in the status of the group’s R&D activities during the interim consolidated accounting period.」
The company disclosed interim R&D expenses of ¥2,842 million, stating that there had been no material changes in the status of its R&D activities. - FY2024-Q3RestatedAnnual report
「The group’s total R&D expenses for the cumulative third quarter were ¥4,480 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter.」
The company disclosed cumulative third-quarter R&D expenses of ¥4,480 million, stating that there had been no material changes in its R&D structure. - FY2024-Q2RestatedAnnual report
「The group’s total R&D expenses for the cumulative second quarter were ¥2,941 million. There were no material changes in the status of the group’s R&D activities during the cumulative second quarter.」
There were no material changes in the status of the group’s R&D activities, and cumulative second-quarter R&D expenses were ¥2,941 million. - FY2024-Q1RestatedAnnual report
「The group’s total R&D expenses for the cumulative first quarter were ¥1,502 million. There were no material changes in the status of the group’s R&D activities during the cumulative first quarter.」
The company disclosed cumulative first-quarter R&D expenses of ¥1,502 million, stating that there had been no material changes in its R&D structure. - FY2023RestatedAnnual report
「The R&D Center serves as the group’s central development function and conducts R&D across the group in line with management policies. Product development, production technology development and other activities related to each business are handled by the product development and technology development divisions of the Watch Business, as well as by each operating company.」
The company continued its structure of central development by the R&D Center and product and production technology development by its operating companies. Full-year R&D expenses were ¥5,693 million. - FY2023-Q3RestatedAnnual report
「The group’s total R&D expenses for the cumulative third quarter were ¥4,283 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter.」
The company disclosed cumulative third-quarter R&D expenses of ¥4,283 million, stating that there had been no material changes in the status of its R&D activities. - FY2023-Q2RestatedAnnual report
「The group’s total R&D expenses for the cumulative second quarter were ¥2,937 million. There were no material changes in the status of the group’s R&D activities during the cumulative second quarter.」
There were no material changes in the status of the group’s R&D activities, and cumulative second-quarter R&D expenses were ¥2,937 million. - FY2023-Q1RestatedAnnual report
「The group’s total R&D expenses for the cumulative first quarter were ¥1,450 million. There were no material changes in the status of the group’s R&D activities during the cumulative first quarter.」
The company disclosed cumulative first-quarter R&D expenses of ¥1,450 million, stating that there had been no material changes in the status of its R&D activities. - FY2022-Q3RestatedAnnual report
「The group’s total R&D expenses for the cumulative third quarter were ¥4,006 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter.」
The company’s R&D expenses were ¥4,006 million, and there had been no material changes in the status of its R&D activities. - FY2022-Q2RestatedAnnual report
「The group’s total R&D expenses for the cumulative second quarter were ¥2,560 million. There were no material changes in the status of the group’s R&D activities during the cumulative second quarter.」
The company disclosed cumulative second-quarter R&D expenses of ¥2,560 million, stating that there had been no material changes in the status of its R&D activities. - FY2022-Q1RestatedAnnual report
「The group’s total R&D expenses for the cumulative first quarter were ¥1,331 million. There were no material changes in the status of the group’s R&D activities during the cumulative first quarter.」
There were no material changes in the group’s R&D activities, and cumulative first-quarter R&D expenses were ¥1,331 million. - FY2021-Q3RestatedAnnual report
「The group’s total R&D expenses for the cumulative third quarter were ¥4,057 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter.」
The company disclosed cumulative third-quarter R&D expenses of ¥4,057 million, stating that there had been no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「The group’s total R&D expenses for the cumulative second quarter were ¥2,804 million. There were no material changes in the status of the group’s R&D activities during the cumulative second quarter.」
The company disclosed cumulative second-quarter R&D expenses of ¥2,804 million, stating that there had been no material changes in its R&D activities. - FY2021-Q1RestatedAnnual report
「The group’s total R&D expenses for the cumulative first quarter were ¥1,485 million. There were no material changes in the status of the group’s R&D activities during the cumulative first quarter.」
The company disclosed cumulative first-quarter R&D expenses of ¥1,485 million, stating that there had been no material changes in its R&D activities. - FY2020RestatedAnnual report
「The R&D Center serves as the group’s central development function and conducts R&D across the group in line with management policies. Product development, production technology development and other activities related to each business are handled by the product development and technology development divisions of the Watch Business, as well as by each operating company.」
The company has continued its structure of central development by the R&D Center and business-specific development by the Watch Business division and each operating company. - FY2020-Q3RestatedAnnual report
「The group’s total R&D expenses for the cumulative third quarter were ¥4,562 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter.」
The company disclosed cumulative third-quarter R&D expenses of ¥4,562 million, stating that there had been no material changes in its R&D activities. - FY2020-Q2RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative second quarter of the current fiscal year was ¥3,093 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current fiscal year.」
The company disclosed R&D expenses of ¥3,093 million for the cumulative second quarter, stating that there had been no material changes in its R&D activities. - FY2019-Q3RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative third quarter of the current fiscal year was ¥4,878 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative third-quarter R&D expenses of ¥4,878 million. - FY2019-Q2RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative second quarter of the current fiscal year was ¥3,269 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current fiscal year.」
There were no material changes in R&D activities, and cumulative second-quarter R&D expenses were ¥3,269 million. - FY2019-Q1RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative first quarter of the current fiscal year was ¥1,765 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative first-quarter R&D expenses of ¥1,765 million. - FY2018ReframedAnnual report
「Under the R&D structure, the R&D Center provides the central development function and conducts group-wide R&D in line with management policy. The Watch Development Division, Product Management Division and each operating company are responsible for product development, production technology development and other activities related to their respective businesses. R&D expenses include ¥1,112 million in basic research costs that cannot be allocated to individual businesses, and R&D expenses invested during the current fiscal year totaled ¥7,161 million.」
The R&D Center is responsible for the central development function, while the Watch Development Division, Product Management Division and each operating company handle business-specific development. Full-year R&D expenses were ¥7,161 million. - FY2018-Q3RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative third quarter of the current fiscal year was ¥5,556 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative third-quarter R&D expenses of ¥5,556 million. - FY2018-Q2RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative second quarter of the current fiscal year was ¥3,867 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative second-quarter R&D expenses of ¥3,867 million. - FY2018-Q1RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative first quarter of the current fiscal year was ¥1,835 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative first-quarter R&D expenses of ¥1,835 million. - FY2017-Q3RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative third quarter of the current fiscal year was ¥5,310 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative third-quarter R&D expenses of ¥5,310 million. - FY2017-Q2RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative second quarter of the current fiscal year was ¥3,477 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current fiscal year.」
The company stated that there were no material changes in R&D activities and disclosed cumulative second-quarter R&D expenses of ¥3,477 million. - FY2017-Q1RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative first quarter of the current fiscal year was ¥1,697 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current fiscal year.」
There were no material changes in R&D activities, and R&D expenses for the cumulative quarter were reported at ¥1,697 million. - FY2016First statedAnnual report
「Citizen Holdings Co., Ltd. provides the central development function and conducts R&D from a group-wide perspective, aligned with management policy, while each operating company is responsible for product development, production technology development and other activities related to its respective business.」
The company adopts a structure that combines the central development function with product and production technology development by each operating company, and reports R&D expenses of ¥7,500 million.